<DOC>
	<DOC>NCT02537002</DOC>
	<brief_summary>The purpose of this study is the following: - To determine the safety and tolerability of single ascending intravenous (IV) doses of PF-05230907 in healthy Japanese subjects. - To characterize the PK profile of single ascending IV doses of PF-05230907 in healthy Japanese subjects. - To characterize the PD profiles of single ascending IV doses of PF-05230907 in healthy Japanese subjects. - To evaluate the immunogenicity of PF-05230907 in healthy Japanese subjects</brief_summary>
	<brief_title>Single Dose Study of PF-05230907 in Healthy Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male of females Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight &gt;50 kg (110 lbs) and &lt;120 kg (265 lbs). Japanese subjects who have four biologic Japanese grandparents born in Japan. Pregnant or nursing females. Females of childbearing potential who are unwilling or unable to use an acceptable method of contraception. Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>PF-05230907</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Immunogenicity</keyword>
</DOC>